共 50 条
- [21] Effect Of β2-Adrenergic Receptor Gene Polymorphism Gly16Arg On Response To Budesonide/Formoterol Pressurized Metered-Dose Inhaler In Chronic Obstructive Pulmonary DiseaseAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183Bleecker, E. R.Meyers, D. A.Bailey, W. C.Sims, A. -M.Bujac, S. R.Goldman, M.Martin, U. J.
- [22] BRONCHODILATOR REVERSIBILITY AND ONSET WITH BUDESONID/FORMOTEROL PRESSURIZED METERED-DOSE INHALER (BUD/FM PMDI) IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A61 - A61Celli, B. R.Tashkin, D. P.Rennard, S. I.McElhattan, J.Martin, U. J.
- [23] Comparative bronchodilatory effects of formoterol dry powder inhaler (DPI) versus the combination of formoterol and budesonide pressurized metered-dose inhaler (pMDI)JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S248 - S248Mezzanotte, W. S.Miller, C. J.Senn, S.
- [24] Efficacy Outcomes With Budesonide/Formoterol Pressurized Metered-Dose Inhaler (BUD/FM pMDI) According to Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification at Baseline in Patients With Chronic Obstructive Pulmonary Disease (COPD)CHEST, 2013, 144 (04)Tashkin, DonaldRennard, StephenUryniak, TomMartin, UbaldoTrudo, Frank
- [25] Pharmacokinetics of Budesonide and Formoterol Administered Via 1 Pressurized Metered-Dose Inhaler in Patients With Asthma and COPDJOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (11): : 1300 - 1308Tronde, AnnGillen, MichaelBorgstrom, LarsLotvall, JanAnkerst, Jaro
- [26] The effectiveness of large group demonstration training method on the use of pressurized metered-dose inhaler in elderly with chronic obstructive pulmonary diseaseJOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 919 - +Choomuang, WoranootPothirat, ChaicharnChaiwong, WarawutLiwsrisakun, ChalermTheerakittikul, TheerakornPhetsuk, NittayaChanayat, Panida
- [27] Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) studyRESPIRATORY MEDICINE, 2017, 132 : 31 - 41Ferguson, Gary T.Tashkin, Donald P.Skarby, TorJorup, CarinSandin, KristinaGreenwood, MichaelPemberton, KristineTrudo, Frank
- [28] Comparative assessment of asthma control with budesonide and formoterol in one pressurized metered-dose inhaler (pMDI) versus budesonide and formoterol in individual inhalers and placeboJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S248 - S248Corren, J.Korenblat, P. E.Miller, C. J.O'Brien, C. D.Mezzanotte, W. S.
- [30] Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease Results from a 1-Year Randomized Controlled Clinical TrialDRUGS, 2009, 69 (05) : 549 - 565Rennard, Stephen I.Tashkin, Donald P.McElhattan, JenniferGoldman, MitchellRamachandran, SulabhaMartin, Ubaldo J.Silkoff, Philip E.
